+1 877 705 1914• 24 / 7
HIPAA Compliant
ISO 27001 Certified

Actively Recruiting

All Ages
All Genders
ID00816114

Observational Chart Review of Chronic Myelogenous Leukemia Patients Treated with Tyrosine Kinase Inhibitors Outside Clinical Trials at M.D. Anderson Cancer Center

Led by M.D. Anderson Cancer Center · Updated on 2026-10-07

3000

Participants Needed

1

Research Sites

N/A

Total Duration

AI-Summary

What This Trial Is About

Researchers are conducting a chart review of patients with Chronic Myelogenous Leukemia CML treated with tyrosine kinase inhibitors TKIs like imatinib, dasatinib, or nilotinib outside of clinical trials. This study focuses on patients seeking a second opinion at M.D. Anderson Cancer Center MDACC to better understand treatment patterns, follow-up, and outcomes in real-world settings. The review addresses gaps in long-term data and treatment adherence compared to clinical trial participants. The study collects detailed information from patient charts, including demographics, lab results, treatment history, dose changes, interruptions, toxicity, and pregnancy outcomes during TKI therapy. Data are gathered from routine care documentation at MDACC and other institutions, without altering treatments. Researchers will analyze this information to compare efficacy, safety, and prognostic markers with those from clinical trials and literature. Participants are not required to undergo any interventions as the study solely reviews existing medical records from July 1998 to August 2019. Researchers will assess responses to standard-dose imatinib and other TKIs, chromosomal abnormalities, and pregnancy outcomes. This observational study continues until April 2030 and involves approximately 3000 patient charts, allowing comprehensive evaluation of real-world treatment experiences and long-term effects.

CONDITIONS

Brief Title

Chart Review Study of Chronic Myelogenous Leukemia (CML) Patients Treated With Imatinib Outside of a Clinical Trial

Research Team

K

Koji Sasaki, M.D.

S

Sasaki

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here